Mauricio Tohen

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Activities & Behaviors

Schizophrenic Psychology

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Tohen Mauricio; Sniadecki Jennifer; Sutton Virginia K; Degenhardt Elisabeth K; Karagianis Jamie L; Sagman Doron; Jacobson Jennie G
Number needed to treat or harm analyses of olanzapine for maintenance treatment of bipolar disorder.
Vieta E; Berk M; Wang W; Colom F; Tohen M; Baldessarini R J
Predominant previous polarity as an outcome predictor in a controlled treatment trial for depression in bipolar I disorder patients.
Benazzi Franco; Berk Michael; Frye Mark A; Wang Wei; Barraco Alessandra; Tohen Mauricio
Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Mauricio Tohen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Tohen Mauricio; Sniadecki Jennifer; Sutton Virginia K; Degenhardt Elisabeth K; Karagianis Jamie L; Sagman Doron; Jacobson Jennie G
Number needed to treat or harm analyses of olanzapine for maintenance treatment of bipolar disorder.
Journal of clinical psychopharmacology 2009;29(6):520-8.
2009: Vieta E; Berk M; Wang W; Colom F; Tohen M; Baldessarini R J
Predominant previous polarity as an outcome predictor in a controlled treatment trial for depression in bipolar I disorder patients.
Journal of affective disorders 2009;119(1-3):22-7.
2009: Benazzi Franco; Berk Michael; Frye Mark A; Wang Wei; Barraco Alessandra; Tohen Mauricio
Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
The Journal of clinical psychiatry 2009;70(10):1424-31.
2009: Tohen Mauricio; Frank Ellen; Bowden Charles L; Colom Francesc; Ghaemi S Nassir; Yatham Lakshmi N; Malhi Gin S; Calabrese Joseph R; Nolen Willem A; Vieta Eduard; Kapczinski Flávio; Goodwin Guy M; Suppes Trisha; Sachs Gary S; Chengappa Kn Roy; Grunze Heinz; Mitchell Philip B; Kanba Shigenobu; Berk Michael
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders.
Bipolar disorders 2009;11(5):453-73.
2009: Tamayo Jorge M; Sutton Virginia K; Mattei Manuel A; Diaz Barbara; Jamal Hassan H; Vieta Eduard; Zarate Carlos A; Fumero Ileana; Tohen Mauricio
Effectiveness and safety of the combination of fluoxetine and olanzapine in outpatients with bipolar depression: an open-label, randomized, flexible-dose study in Puerto Rico.
Journal of clinical psychopharmacology 2009;29(4):358-61.
2009: Brown Eileen; Dunner David L; McElroy Susan L; Keck Paul E; Adams David H; Degenhardt Elisabeth; Tohen Mauricio; Houston John P
Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2009;12(6):773-82.
2009: Tohen Mauricio; Sutton Virginia K; Calabrese Joseph R; Sachs Gary S; Bowden Charles L
Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder.
Journal of affective disorders 2009;116(1-2):43-50.
2009: Tohen Mauricio; Vieta Eduard
Antipsychotic agents in the treatment of bipolar mania.
Bipolar disorders 2009;11 Suppl 2():45-54.
2009: Thompson Paul M; Bartzokis George; Hayashi Kiralee M; Klunder Andrea D; Lu Po H; Edwards Nancy; Hong Michael S; Yu Michael; Geaga Jennifer A; Toga Arthur W; Charles Cecil; Perkins Diana O; McEvoy Joseph; Hamer Robert M; Tohen Mauricio; Tollefson Gary D; Lieberman Jeffrey A;
Time-lapse mapping of cortical changes in schizophrenia with different treatments.
Cerebral cortex (New York, N.Y. : 1991) 2009;19(5):1107-23.
2009: Salvatore Paola; Baldessarini Ross J; Tohen Mauricio; Khalsa Hari-Mandir K; Sanchez-Toledo Jesus Perez; Zarate Carlos A; Vieta Eduard; Maggini Carlo
McLean-Harvard International First-Episode Project: two-year stability of DSM-IV diagnoses in 500 first-episode psychotic disorder patients.
The Journal of clinical psychiatry 2009;70(4):458-66.
2009: Carlson Gabrielle A; Findling Robert L; Post Robert M; Birmaher Boris; Blumberg Hilary P; Correll Christoph; DelBello Melissa P; Fristad Mary; Frazier Jean; Hammen Constance; Hinshaw Stephen P; Kowatch Robert; Leibenluft Ellen; Meyer Stephanie E; Pavuluri Mani N; Wagner Karen Dineen; Tohen Mauricio
AACAP 2006 Research Forum--Advancing research in early-onset bipolar disorder: barriers and suggestions.
Journal of child and adolescent psychopharmacology 2009;19(1):3-12.
2009: Kryzhanovskaya Ludmila; Schulz S Charles; McDougle Christopher; Frazier Jean; Dittmann Ralf; Robertson-Plouch Carol; Bauer Theresa; Xu Wen; Wang Wei; Carlson Janice; Tohen Mauricio
Olanzapine versus placebo in adolescents with schizophrenia: a 6-week, randomized, double-blind, placebo-controlled trial.
Journal of the American Academy of Child and Adolescent Psychiatry 2009;48(1):60-70.
2008: Tohen Mauricio; Vieta Eduard; Goodwin Guy M; Sun Bin; Amsterdam Jay D; Banov Michael; Shekhar Anantha; Aaronson Scott T; Bardenstein Leonid; Grecu-Gabos Iosif; Tochilov Vladimir; Prelipceanu Dan; Oliff Heather S; Kryzhanovskaya Ludmila; Bowden Charles
Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study.
The Journal of clinical psychiatry 2008;69(11):1776-89.
2008: Ascher-Svanum Haya; Zhu Baojin; Faries Douglas; Peng Xiaomei; Kinon Bruce J; Tohen Mauricio
Tardive dyskinesia and the 3-year course of schizophrenia: results from a large, prospective, naturalistic study.
The Journal of clinical psychiatry 2008;69(10):1580-8.
2008: Hawkins Keith A; Keefe Richard S E; Christensen Bruce K; Addington Jean; Woods Scott W; Callahan Jennifer; Zipursky Robert B; Perkins Diana O; Tohen Mauricio; Breier Alan; McGlashan Thomas H
Neuropsychological course in the prodrome and first episode of psychosis: findings from the PRIME North America Double Blind Treatment Study.
Schizophrenia research 2008;105(1-3):1-9.
2008: Baethge Christopher; Hennen John; Khalsa Hari-Mandir Kaur; Salvatore Paola; Tohen Mauricio; Baldessarini Ross J
Sequencing of substance use and affective morbidity in 166 first-episode bipolar I disorder patients.
Bipolar disorders 2008;10(6):738-41.
2008: Berk Michael; Ng Felicity; Wang Wei V; Tohen Mauricio; Lubman Dan I; Vieta Eduard; Dodd Seetal
Going up in smoke: tobacco smoking is associated with worse treatment outcomes in mania.
Journal of affective disorders 2008;110(1-2):126-34.
2008: Tohen Mauricio
Clinical trials in bipolar mania: implications in study design and drug development.
Archives of general psychiatry 2008;65(3):252-3.
2008: Tohen Mauricio; Bowden Charles L; Smulevich Anatoly B; Bergstrom Richard; Quinlan Tonya; Osuntokun Olawale; Wang Wei V; Oliff Heather S; Martenyi Ferenc; Kryzhanovskaya Ludmila A; Greil Waldemar
Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes.
The British journal of psychiatry : the journal of mental science 2008;192(2):135-43.
2008: Berk Michael; Ng Felicity; Wang Wei V; Calabrese Joseph R; Mitchell Philip B; Malhi Gin S; Tohen Mauricio
The empirical redefinition of the psychometric criteria for remission in bipolar disorder.
Journal of affective disorders 2008;106(1-2):153-8.
2008: Khalsa Hari Mandir Kaur; Salvatore Paola; Hennen John; Baethge Christopher; Tohen Mauricio; Baldessarini Ross J
Suicidal events and accidents in 216 first-episode bipolar I disorder patients: predictive factors.
Journal of affective disorders 2008;106(1-2):179-84.
2008: Vieta Eduard; Panicali Francesco; Goetz Iris; Reed Catherine; Comes Merce; Tohen Mauricio;
Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study.
Journal of affective disorders 2008;106(1-2):63-72.
2008: Niufan Gu; Tohen Mauricio; Qiuqing Ang; Fude Yang; Pope Elizabeth; McElroy Heather; Ming Li; Gaohua Wang; Xinbao Zhang; Huichun Li; Liang Shu
Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.
Journal of affective disorders 2008;105(1-3):101-8.
2007: Tohen Mauricio; Calabrese Joseph; Vieta Eduard; Bowden Charles; Gonzalez-Pinto Ana; Lin Daniel; Xu Wen; Corya Sara
Effect of comorbid anxiety on treatment response in bipolar depression.
Journal of affective disorders 2007;104(1-3):137-46.
2007: Salvatore P; Khalsa H M K; Hennen J; Tohen M; Yurgelun-Todd D; Casolari F; Depanfilis C; Maggini C; Baldessarini R J
Psychopathology factors in first-episode affective and non-affective psychotic disorders.
Journal of psychiatric research 2007;41(9):724-36.
2007: Hoffman Ralph E; Woods Scott W; Hawkins Keith A; Pittman Brian; Tohen Mauricio; Preda Adrian; Breier Alan; Glist Jill; Addington Jean; Perkins Diana O; McGlashan Thomas H
Extracting spurious messages from noise and risk of schizophrenia-spectrum disorders in a prodromal population.
The British journal of psychiatry : the journal of mental science 2007;191():355-6.
2007: Tohen Mauricio; Kryzhanovskaya Ludmila; Carlson Gabrielle; Delbello Melissa; Wozniak Janet; Kowatch Robert; Wagner Karen; Findling Robert; Lin Daniel; Robertson-Plouch Carol; Xu Wen; Dittmann Ralf W; Biederman Joseph
Olanzapine versus placebo in the treatment of adolescents with bipolar mania.
The American journal of psychiatry 2007;164(10):1547-56.
2007: Karagianis Jamie; Rosenbluth Michael; Tohen Mauricio; Ascher-Svanum Haya; Treuer Tamas; de Lima Mauricio Silva; Citrome Leslie
Reviewing CATIE for clinicians: balancing benefit and risk using evidence-based medicine tools.
Current medical research and opinion 2007;23(10):2551-7.
2007: Dubé Sanjay; Tollefson Gary D; Thase Michael E; Briggs Susan D; Van Campen Luann E; Case Michael; Tohen Mauricio
Onset of antidepressant effect of olanzapine and olanzapine/fluoxetine combination in bipolar depression.
Bipolar disorders 2007;9(6):618-27.
2007: Berk Michael; Malhi Gin S; Cahill Catherine; Carman A Catherine; Hadzi-Pavlovic Dusan; Hawkins Mary T; Tohen Mauricio; Mitchell Philip B
The Bipolar Depression Rating Scale (BDRS): its development, validation and utility.
Bipolar disorders 2007;9(6):571-9.
2007: Tohen Mauricio
Collaborations between academic psychiatry and the pharmaceutical industry: a perspective from industry.
Epidemiologia e psichiatria sociale 2007;16(3):197-8.
2007: Baldessarini Ross J; Tondo Leonardo; Strombom Indiana M; Dominguez Svetlana; Fawcett Jan; Licinio Julio; Oquendo Maria A; Tollefson Gary D; Valuck Robert J; Tohen Mauricio
Ecological studies of antidepressant treatment and suicidal risks.
Harvard review of psychiatry 2007;15(4):133-45.
2007: Salvatore Paola; Tohen Mauricio; Khalsa Hari-Mandir Kaur; Baethge Christopher; Tondo Leonardo; Baldessarini Ross J
Longitudinal research on bipolar disorders.
Epidemiologia e psichiatria sociale 2007;16(2):109-17.
2007: Tamayo Jorge M; Mazzotti Guido; Tohen Mauricio; Gattaz Wagner F; Zapata Ricardo; Castillo José J; Fahrer Rodolfo D; González-Pinto Ana M; Vieta Eduard; Azorin Jean M; Brown Eileen; Brunner Elizabeth; Rovner Jorge; Bonett-Perrin Elena; Baker Robert W
Outcomes for Latin American versus White patients suffering from acute mania in a randomized, double-blind trial comparing olanzapine and haloperidol.
Journal of clinical psychopharmacology 2007;27(2):126-34.
2007: Rosso Isabelle M; Killgore William D S; Cintron Christina M; Gruber Staci A; Tohen Mauricio; Yurgelun-Todd Deborah A
Reduced amygdala volumes in first-episode bipolar disorder and correlation with cerebral white matter.
Biological psychiatry 2007;61(6):743-9.
2007: Goetz I; Tohen M; Reed C; Lorenzo M; Vieta E;
Functional impairment in patients with mania: baseline results of the EMBLEM study.
Bipolar disorders 2007;9(1-2):45-52.
2007: Paul Steven M; Tohen Mauricio
Conflicts of interest and the credibility of psychiatric research.
World psychiatry : official journal of the World Psychiatric Association (WPA) 2007;6(1):33-4.
2006: Tohen Mauricio; Bowden Charles L; Calabrese Joseph R; Lin Daniel; Forrester Tammy D; Sachs Gary S; Koukopoulos Athanasios; Yatham Lakshmi; Grunze Heinz
Influence of sub-syndromal symptoms after remission from manic or mixed episodes.
The British journal of psychiatry : the journal of mental science 2006;189():515-9.
2006: Perlis Roy H; Baker Robert W; Zarate Carlos A; Brown Eileen B; Schuh Leslie M; Jamal Hassan H; Tohen Mauricio
Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial.
The Journal of clinical psychiatry 2006;67(11):1747-53.
2006: McEvoy Joseph P; Johnson Jackie; Perkins Diana; Lieberman Jeffrey A; Hamer Robert M; Keefe Richard S E; Tohen Mauricio; Glick Ira D; Sharma Tonmoy
Insight in first-episode psychosis.
Psychological medicine 2006;36(10):1385-93.
2006: Green A I; Lieberman J A; Hamer R M; Glick I D; Gur R E; Kahn R S; McEvoy J P; Perkins D O; Rothschild A J; Sharma T; Tohen M F; Woolson S; Zipursky R B;
Olanzapine and haloperidol in first episode psychosis: two-year data.
Schizophrenia research 2006;86(1-3):234-43.
2006: Houston John P; Ahl Jonna; Meyers Adam L; Kaiser Christopher J; Tohen Mauricio; Baldessarini Ross J
Reduced suicidal ideation in bipolar I disorder mixed-episode patients in a placebo-controlled trial of olanzapine combined with lithium or divalproex.
The Journal of clinical psychiatry 2006;67(8):1246-52.
2006: Brown Eileen B; McElroy Susan L; Keck Paul E; Deldar Ahmed; Adams David H; Tohen Mauricio; Williamson Douglas J
A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression.
The Journal of clinical psychiatry 2006;67(7):1025-33.
2006: Williamson Doug; Brown Eileen; Perlis Roy H; Ahl Jonna; Baker Robert W; Tohen Mauricio
Clinical relevance of depressive symptom improvement in bipolar I depressed patients.
Journal of affective disorders 2006;92(2-3):261-6.
2006: Corya Sara A; Perlis Roy H; Keck Paul E; Lin Daniel Y; Case Michael G; Williamson Doug J; Tohen Mauricio F
A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression.
The Journal of clinical psychiatry 2006;67(5):798-806.
2006: Shi Lizheng; Juarez Rodrigo; Hackworth Jodi; Edgell Eric T; Haro Josep Maria; Vieta Eduard; Tohen Mauricio F
Open-label olanzapine treatment in bipolar I disorder: clinical and work functional outcomes.
Current medical research and opinion 2006;22(5):961-6.
2006: McGlashan Thomas H; Zipursky Robert B; Perkins Diana; Addington Jean; Miller Tandy; Woods Scott W; Hawkins Keith A; Hoffman Ralph E; Preda Adrian; Epstein Irvin; Addington Donald; Lindborg Stacy; Trzaskoma Quynh; Tohen Mauricio; Breier Alan
Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis.
The American journal of psychiatry 2006;163(5):790-9.
2006: Dando Simon; Tohen Mauricio
Olanzapine - relapse prevention following mania.
Journal of psychopharmacology (Oxford, England) 2006;20(2 Suppl):31-8.
2006: Perkins Diana O; Johnson Jacqueline L; Hamer Robert M; Zipursky Robert B; Keefe Richard S; Centorrhino Franca; Green Alan I; Glick Ira B; Kahn Rene S; Sharma Tonmoy; Tohen Mauricio; McEvoy Joseph P; Weiden Peter J; Lieberman Jeffrey A;
Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode.
Schizophrenia research 2006;83(1):53-63.
2006: Tohen Mauricio; Calabrese Joseph R; Sachs Gary S; Banov Michael D; Detke Holland C; Risser Richard; Baker Robert W; Chou James C-Y; Bowden Charles L
Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine.
The American journal of psychiatry 2006;163(2):247-56.
2006: Cavazzoni Patrizia A; Berg Paul H; Kryzhanovskaya Ludmila A; Briggs Susan D; Roddy Tamra E; Tohen Mauricio; Kane John M
Comparison of treatment-emergent extrapyramidal symptoms in patients with bipolar mania or schizophrenia during olanzapine clinical trials.
The Journal of clinical psychiatry 2006;67(1):107-13.
2006: Ketter Terence A; Houston John P; Adams David H; Risser Richard C; Meyers Adam L; Williamson Douglas J; Tohen Mauricio
Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes.
The Journal of clinical psychiatry 2006;67(1):95-101.
2006: Keefe Richard S E; Seidman Larry J; Christensen Bruce K; Hamer Robert M; Sharma Tonmoy; Sitskoorn Margriet M; Rock Stephanie L; Woolson Sandra; Tohen Mauricio; Tollefson Gary D; Sanger Todd M; Lieberman Jeffrey A;
Long-term neurocognitive effects of olanzapine or low-dose haloperidol in first-episode psychosis.
Biological psychiatry 2006;59(2):97-105.
2005: Zipursky Robert B; Gu Hongbin; Green Alan I; Perkins Diana O; Tohen Mauricio F; McEvoy Joseph P; Strakowski Stephen M; Sharma Tonmoy; Kahn René S; Gur Raquel E; Tollefson Gary D; Lieberman Jeffrey A
Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol.
The British journal of psychiatry : the journal of mental science 2005;187():537-43.
2005: Suppes Trisha; Brown Eileen; Schuh Leslie M; Baker Robert W; Tohen Mauricio
Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data.
Journal of affective disorders 2005;89(1-3):69-77.
2005: Strakowski Stephen M; Johnson Jacqueline L; Delbello Melissa P; Hamer Robert M; Green Alan I; Tohen Mauricio; Lieberman Jeffrey A; Glick Ira; Patel Jayendra K;
Quality of life during treatment with haloperidol or olanzapine in the year following a first psychotic episode.
Schizophrenia research 2005;78(2-3):161-9.
2005: Tohen Mauricio; Greil Waldemar; Calabrese Joseph R; Sachs Gary S; Yatham Lakshmi N; Oerlinghausen Bruno Müller; Koukopoulos Athanasios; Cassano Giovanni B; Grunze Heinz; Licht Rasmus W; Dell'Osso Liliana; Evans Angela R; Risser Richard; Baker Robert W; Crane Heidi; Dossenbach Martin R; Bowden Charles L
Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.
The American journal of psychiatry 2005;162(7):1281-90.
2005: Keck Paul E; Corya Sara A; Altshuler Lori L; Ketter Terence A; McElroy Susan L; Case Michael; Briggs Susan D; Tohen Mauricio
Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression.
The Journal of clinical psychiatry 2005;66(5):611-6.
2005: Baethge Christopher; Baldessarini Ross J; Khalsa Hari-Mandir Kaur; Hennen John; Salvatore Paola; Tohen Mauricio
Substance abuse in first-episode bipolar I disorder: indications for early intervention.
The American journal of psychiatry 2005;162(5):1008-10.
2005: Zhu Baojin; Tunis Sandra L; Zhao Zhongyun; Baker Robert W; Lage Maureen J; Shi Lizheng; Tohen Mauricio
Service utilization and costs of olanzapine versus divalproex treatment for acute mania: results from a randomized, 47-week clinical trial.
Current medical research and opinion 2005;21(4):555-64.
2005: Lieberman Jeffrey A; Tollefson Gary D; Charles Cecil; Zipursky Robert; Sharma Tonmoy; Kahn Rene S; Keefe Richard S E; Green Alan I; Gur Raquel E; McEvoy Joseph; Perkins Diana; Hamer Robert M; Gu Hongbin; Tohen Mauricio;
Antipsychotic drug effects on brain morphology in first-episode psychosis.
Archives of general psychiatry 2005;62(4):361-70.
2005: Chengappa K N Roy; Hennen John; Baldessarini Ross J; Kupfer David J; Yatham Lakshmi N; Gershon Samuel; Baker Robert W; Tohen Mauricio
Recovery and functional outcomes following olanzapine treatment for bipolar I mania.
Bipolar disorders 2005;7(1):68-76.
2004: Hennen John; Perlis Roy H; Sachs Gary; Tohen Mauricio; Baldessarini Ross J
Weight gain during treatment of bipolar I patients with olanzapine.
The Journal of clinical psychiatry 2004;65(12):1679-87.
2004: Baker Robert W; Brown Eileen; Akiskal Hagop S; Calabrese Joseph R; Ketter Terence A; Schuh Leslie M; Trzepacz Paula T; Watkin John G; Tohen Mauricio
Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania.
The British journal of psychiatry : the journal of mental science 2004;185():472-8.
2004: Vieta Eduard; Calabrese Joseph R; Hennen John; Colom Francesc; Martínez-Arán Anabel; Sánchez-Moreno Jose; Yatham Lakshmi N; Tohen Mauricio; Baldessarini Ross J
Comparison of rapid-cycling and non-rapid-cycling bipolar I manic patients during treatment with olanzapine: analysis of pooled data.
The Journal of clinical psychiatry 2004;65(10):1420-8.
2004: Shi Lizheng; Schuh Leslie M; Trzepacz Paula T; Huang Linda X; Namjoshi Madhav A; Tohen Mauricio
Improvement of Positive and Negative Syndrome Scale cognitive score associated with olanzapine treatment of acute mania.
Current medical research and opinion 2004;20(9):1371-6.
2004: Namjoshi Madhav A; Risser Richard; Shi Lizheng; Tohen Mauricio; Breier Alan
Quality of life assessment in patients with bipolar disorder treated with olanzapine added to lithium or valproic acid.
Journal of affective disorders 2004;81(3):223-9.
2004: Rothschild Anthony J; Williamson Douglas J; Tohen Mauricio F; Schatzberg Alan; Andersen Scott W; Van Campen Luann E; Sanger Todd M; Tollefson Gary D
A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features.
Journal of clinical psychopharmacology 2004;24(4):365-73.
2004: Perkins Diana; Lieberman Jeffrey; Gu Hongbin; Tohen Mauricio; McEvoy Joseph; Green Alan; Zipursky Robert; Strakowski Stephen; Sharma Tonmoy; Kahn René; Gur Raquel; Tollefson Gary;
Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders.
The British journal of psychiatry : the journal of mental science 2004;185():18-24.
2004: Keefe Richard S E; Seidman Larry J; Christensen Bruce K; Hamer Robert M; Sharma Tonmoy; Sitskoorn Margriet M; Lewine Richard R J; Yurgelun-Todd Deborah A; Gur Ruben C; Tohen Mauricio; Tollefson Gary D; Sanger Todd M; Lieberman Jeffrey A
Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol.
The American journal of psychiatry 2004;161(6):985-95.
2004: Lindenmayer Jean-Pierre; Brown Eileen; Baker Robert W; Schuh Leslie M; Shao Lixin; Tohen Mauricio; Ahmed Saeeduddin; Stauffer Virginia L
An excitement subscale of the Positive and Negative Syndrome Scale.
Schizophrenia research 2004;68(2-3):331-7.
2004: Tohen Mauricio; Chengappa K N Roy; Suppes Trisha; Baker Robert W; Zarate Carlos A; Bowden Charles L; Sachs Gary S; Kupfer David J; Ghaemi S Nassir; Feldman Peter D; Risser Richard C; Evans Angela R; Calabrese Joseph R
Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone.
The British journal of psychiatry : the journal of mental science 2004;184():337-45.
2004: Green Alan I; Tohen Mauricio F; Hamer Robert M; Strakowski Stephen M; Lieberman Jeffrey A; Glick Ira; Clark W Scott;
First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol.
Schizophrenia research 2004;66(2-3):125-35.
2004: Shi Lizheng; Namjoshi Madhav A; Swindle Ralph; Yu Xiaomin; Risser Richard; Baker Robert W; Tohen Mauricio
Effects of olanzapine alone and olanzapine/fluoxetine combination on health-related quality of life in patients with bipolar depression: secondary analyses of a double-blind, placebo-controlled, randomized clinical trial.
Clinical therapeutics 2004;26(1):125-34.
2004: Zarate Carlos A; Tohen Mauricio
Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients.
The American journal of psychiatry 2004;161(1):169-71.
2003: Tohen Mauricio; Goldberg Joseph F; Gonzalez-Pinto Arrillaga Ana Maria; Azorin Jean M; Vieta Eduard; Hardy-Bayle Marie-Christine; Lawson William B; Emsley Robin A; Zhang Fan; Baker Robert W; Risser Richard C; Namjoshi Madhav A; Evans Angela R; Breier Alan
A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania.
Archives of general psychiatry 2003;60(12):1218-26.
2003: Tohen Mauricio; Zarate Carlos A; Hennen John; Khalsa Hari-Mandir Kaur; Strakowski Stephen M; Gebre-Medhin Priscilla; Salvatore Paola; Baldessarini Ross J
The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence.
The American journal of psychiatry 2003;160(12):2099-107.
2003: Tohen Mauricio; Vieta Eduard; Calabrese Joseph; Ketter Terence A; Sachs Gary; Bowden Charles; Mitchell Philip B; Centorrino Franca; Risser Richard; Baker Robert W; Evans Angela R; Beymer Karin; Dube Sanjay; Tollefson Gary D; Breier Alan
Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.
Archives of general psychiatry 2003;60(11):1079-88.
2003: Baldessarini Ross J; Hennen John; Wilson Michael; Calabrese Joseph; Chengappa Roy; Keck Paul E; McElroy Susan L; Sachs Gary; Vieta Eduard; Welge Jeffrey A; Yatham Lakshmi N; Zarate Carlos A; Baker Robert W; Tohen Mauricio
Olanzapine versus placebo in acute mania: treatment responses in subgroups.
Journal of clinical psychopharmacology 2003;23(4):370-6.
2003: Woods Scott W; Breier Alan; Zipursky Robert B; Perkins Diana O; Addington Jean; Miller Tandy J; Hawkins Keith A; Marquez Eva; Lindborg Stacy R; Tohen Mauricio; McGlashan Thomas H
Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome.
Biological psychiatry 2003;54(4):453-64.
2003: Lieberman Jeffrey A; Tollefson Gary; Tohen Mauricio; Green Alan I; Gur Raquel E; Kahn Rene; McEvoy Joseph; Perkins Diana; Sharma Tonmoy; Zipursky Robert; Wei Hank; Hamer Robert M;
Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol.
The American journal of psychiatry 2003;160(8):1396-404.
2003: Tohen Mauricio; Ketter Terence A; Zarate Carlos A; Suppes Trisha; Frye Mark; Altshuler Lori; Zajecka John; Schuh Leslie M; Risser Richard C; Brown Eileen; Baker Robert W
Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study.
The American journal of psychiatry 2003;160(7):1263-71.
2003: Miller T J; Zipursky R B; Perkins D; Addington J; Woods S W; Hawkins K A; Hoffman R; Preda A; Epstein I; Addington D; Lindborg S; Marquez E; Tohen M; Breier A; McGlashan T H
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample.
Schizophrenia research 2003;61(1):19-30.
2003: McGlashan T H; Zipursky R B; Perkins D; Addington J; Miller T J; Woods S W; Hawkins K A; Hoffman R; Lindborg S; Tohen M; Breier A
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design.
Schizophrenia research 2003;61(1):7-18.
2003: Baker Robert W; Tohen Mauricio; Fawcett Jan; Risser Richard C; Schuh Leslie M; Brown Eileen; Stauffer Virginia L; Shao Lixin; Tollefson Gary D
Acute dysphoric mania: treatment response to olanzapine versus placebo.
Journal of clinical psychopharmacology 2003;23(2):132-7.
2003: Chengappa K N Roy; Baker Robert W; Shao Lixin; Yatham Lakshmi N; Tohen Mauricio; Gershon Samuel; Kupfer David J
Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for bipolar mania.
Bipolar disorders 2003;5(1):1-5.
2003: Sanger Todd M; Tohen Mauricio; Vieta Eduard; Dunner David L; Bowden Charles L; Calabrese Joseph R; Feldman Peter D; Jacobs Thomas G; Breier Alan
Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling.
Journal of affective disorders 2003;73(1-2):155-61.
2003: Baker Robert W; Milton Denái R; Stauffer Virginia L; Gelenberg Alan; Tohen Mauricio
Placebo-controlled trials do not find association of olanzapine with exacerbation of bipolar mania.
Journal of affective disorders 2003;73(1-2):147-53.
2003: DelBello Melissa P; Carlson Gabrielle A; Tohen Mauricio; Bromet Evelyn J; Schwiers Michael; Strakowski Stephen M
Rates and predictors of developing a manic or hypomanic episode 1 to 2 years following a first hospitalization for major depression with psychotic features.
Journal of child and adolescent psychopharmacology 2003;13(2):173-85.
2002: Russo Patricia; Smith Mark W; Dirani Riad; Namjoshi Madhav; Tohen Mauricio
Pharmacotherapy patterns in the treatment of bipolar disorder.
Bipolar disorders 2002;4(6):366-77.
2002: Gonzalez-Pinto Ana; Tohen M; Lalaguna B; Pérez-Heredia J L; Fernandez-Corres B; Gutierrez M; Micó J A
Treatment of bipolar I rapid cycling patients during dysphoric mania with olanzapine.
Journal of clinical psychopharmacology 2002;22(5):450-4.
2002: Shi L; Namjoshi M A; Zhang F; Gandhi G; Edgell E T; Tohen M; Breier A; Haro J M
Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status.
International clinical psychopharmacology 2002;17(5):227-37.
2002: Tohen Mauricio; Baker Robert W; Altshuler Lori L; Zarate Carlos A; Suppes Trisha; Ketter Terrence A; Milton Denai R; Risser Richard; Gilmore Julie A; Breier Alan; Tollefson Gary A
Olanzapine versus divalproex in the treatment of acute mania.
The American journal of psychiatry 2002;159(6):1011-7.
2002: Namjoshi Madhav A; Rajamannar Gopalan; Jacobs Thomas; Sanger Todd M; Risser Richard; Tohen Mauricio F; Breier Alan; Keck Paul E
Economic, clinical, and quality-of-life outcomes associated with olanzapine treatment in mania. Results from a randomized controlled trial.
Journal of affective disorders 2002;69(1-3):109-18.
2002: Goldstein Jill M; Cohen Lee S; Horton Nicholas J; Lee Hang; Andersen Scott; Tohen Mauricio; Crawford Ann- Marie K; Tollefson Gary
Sex differences in clinical response to olanzapine compared with haloperidol.
Psychiatry research 2002;110(1):27-37.
2002: McCarley Robert W; Salisbury Dean F; Hirayasu Yoshio; Yurgelun-Todd Deborah A; Tohen Mauricio; Zarate Carlos; Kikinis Ron; Jolesz Ferenc A; Shenton Martha E
Association between smaller left posterior superior temporal gyrus volume on magnetic resonance imaging and smaller left temporal P300 amplitude in first-episode schizophrenia.
Archives of general psychiatry 2002;59(4):321-31.
2002: Baker Robert W; Goldberg Joseph F; Tohen Maurico; Milton Denái R; Stauffer Virginia L; Schuh Leslie M
The impact of response to previous mood stabilizer therapy on response to olanzapine versus placebo for acute mania.
Bipolar disorders 2002;4(1):43-9.
2002: Tohen Mauricio; Chengappa K N Roy; Suppes Trisha; Zarate Carlos A; Calabrese Joseph R; Bowden Charles L; Sachs Gary S; Kupfer David J; Baker Robert W; Risser Richard C; Keeter Elisabeth L; Feldman Peter D; Tollefson Gary D; Breier Alan
Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.
Archives of general psychiatry 2002;59(1):62-9.
2001: Tohen M; Zhang F; Keck P E; Feldman P D; Risser R C; Tran P V; Breier A
Olanzapine versus haloperidol in schizoaffective disorder, bipolar type.
Journal of affective disorders 2001;67(1-3):133-40.
2001: Gonzalez-Pinto A; Lalaguna B; Mosquera F; Pérez de Heredia J L; Gutierrez M; Ezcurra J; Gilaberte I; Tohen M
Use of olanzapine in dysphoric mania.
Journal of affective disorders 2001;66(2-3):247-53.
2001: Lim P Z; Tunis S L; Edell W S; Jensik S E; Tohen M
Medication prescribing patterns for patients with bipolar I disorder in hospital settings: adherence to published practice guidelines.
Bipolar disorders 2001;3(4):165-73.
2001: Meehan K; Zhang F; David S; Tohen M; Janicak P; Small J; Koch M; Rizk R; Walker D; Tran P; Breier A
A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania.
Journal of clinical psychopharmacology 2001;21(4):389-97.
2001: Costa e Silva J A; Alvarez N; Mazzotti G; Gattaz W F; Ospina J; Larach V; Starkstein S; Oliva D; Cousins L; Tohen M; Taylor C C; Wang J; Tran P V
Olanzapine as alternative therapy for patients with haloperidol-induced extrapyramidal symptoms: results of a multicenter, collaborative trial in Latin America.
Journal of clinical psychopharmacology 2001;21(4):375-81.
2001: Tohen M; Zhang F; Taylor C C; Burns P; Zarate C; Sanger T; Tollefson G
A meta-analysis of the use of typical antipsychotic agents in bipolar disorder.
Journal of affective disorders 2001;65(1):85-93.
2001: Sanger T M; Grundy S L; Gibson P J; Namjoshi M A; Greaney M G; Tohen M F
Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.
The Journal of clinical psychiatry 2001;62(4):273-81.
2001: Shelton R C; Tollefson G D; Tohen M; Stahl S; Gannon K S; Jacobs T G; Buras W R; Bymaster F P; Zhang W; Spencer K A; Feldman P D; Meltzer H Y
A novel augmentation strategy for treating resistant major depression.
The American journal of psychiatry 2001;158(1):131-4.
2001: Frazier J A; Biederman J; Tohen M; Feldman P D; Jacobs T G; Toma V; Rater M A; Tarazi R A; Kim G S; Garfield S B; Sohma M; Gonzalez-Heydrich J; Risser R C; Nowlin Z M
A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder.
Journal of child and adolescent psychopharmacology 2001;11(3):239-50.
2000: Chengappa K N; Tohen M; Levine J; Jacobs T; Thase M E; Sanger T M; Kupfer D J
Response to placebo among bipolar I disorder patients experiencing their first manic episode.
Bipolar disorders 2000;2(4):332-5.
2000: Zarate C A; Tohen M; Land M L
First-episode schizophreniform disorder: comparisons with first-episode schizophrenia.
Schizophrenia research 2000;46(1):31-4.
2000: Tohen M; Jacobs T G; Feldman P D
Onset of action of antipsychotics in the treatment of mania.
Bipolar disorders 2000;2(3 Pt 2):261-8.
2000: Tohen M; Strakowski S M; Zarate C; Hennen J; Stoll A L; Suppes T; Faedda G L; Cohen B M; Gebre-Medhin P; Baldessarini R J
The McLean-Harvard first-episode project: 6-month symptomatic and functional outcome in affective and nonaffective psychosis.
Biological psychiatry 2000;48(6):467-76.
2000: Tohen M; Jacobs T G; Grundy S L; McElroy S L; Banov M C; Janicak P G; Sanger T; Risser R; Zhang F; Toma V; Francis J; Tollefson G D; Breier A
Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group.
Archives of general psychiatry 2000;57(9):841-9.
2000: Tohen M; Bromet E; Murphy J M; Tsuang M T
Psychiatric epidemiology.
Harvard review of psychiatry 2000;8(3):111-25.
2000: Green A I; Tohen M; Patel J K; Banov M; DuRand C; Berman I; Chang H; Zarate C; Posener J; Lee H; Dawson R; Richards C; Cole J O; Schatzberg A F
Clozapine in the treatment of refractory psychotic mania.
The American journal of psychiatry 2000;157(6):982-6.
2000: Baldessarini R J; Tohen M; Tondo L
Maintenance treatment in bipolar disorder.
Archives of general psychiatry 2000;57(5):490-2.
2000: Tohen M; Hennen J; Zarate C M; Baldessarini R J; Strakowski S M; Stoll A L; Faedda G L; Suppes T; Gebre-Medhin P; Cohen B M
Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features.
The American journal of psychiatry 2000;157(2):220-8.
1999: Tohen M; Sanger T M; McElroy S L; Tollefson G D; Chengappa K N; Daniel D G; Petty F; Centorrino F; Wang R; Grundy S L; Greaney M G; Jacobs T G; David S R; Toma V
Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group.
The American journal of psychiatry 1999;156(5):702-9.
1999: Sanger T M; Lieberman J A; Tohen M; Grundy S; Beasley C; Tollefson G D
Olanzapine versus haloperidol treatment in first-episode psychosis.
The American journal of psychiatry 1999;156(1):79-87.
1999: Tohen M; Grundy S
Management of acute mania.
The Journal of clinical psychiatry 1999;60 Suppl 5():31-4; discussion 35-6.
1998: Hirayasu Y; Shenton M E; Salisbury D F; Dickey C C; Fischer I A; Mazzoni P; Kisler T; Arakaki H; Kwon J S; Anderson J E; Yurgelun-Todd D; Tohen M; McCarley R W
Lower left temporal lobe MRI volumes in patients with first-episode schizophrenia compared with psychotic patients with first-episode affective disorder and normal subjects.
The American journal of psychiatry 1998;155(10):1384-91.
1998: Kwon J S; Shenton M E; Hirayasu Y; Salisbury D F; Fischer I A; Dickey C C; Yurgelun-Todd D; Tohen M; Kikinis R; Jolesz F A; McCarley R W
MRI study of cavum septi pellucidi in schizophrenia, affective disorder, and schizotypal personality disorder.
The American journal of psychiatry 1998;155(4):509-15.
1998: Stormberg D; Ronningstam E; Gunderson J; Tohen M
Brief communication: pathological narcissism in bipolar disorder patients.
Journal of personality disorders 1998;12(2):179-85.
1998: Tohen M; Zarate C A
Antipsychotic agents and bipolar disorder.
The Journal of clinical psychiatry 1998;59 Suppl 1():38-48; discussion 49.
1997: Revicki D A; Tohen M; Gyulai L; Thompson C; Pike S; Davis-Vogel A; Zarate C
Telephone versus in-person clinical and health status assessment interviews in patients with bipolar disorder.
Harvard review of psychiatry 1997;5(2):75-81.
1997: Gardner D M; Baldessarini R J; Benzo J; Zarate C A; Tohen M
Switching between clozapine and risperidone treatment.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 1997;42(4):430-1.
1997: Viguera A C; Baldessarini R J; Hegarty J D; van Kammen D P; Tohen M
Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment.
Archives of general psychiatry 1997;54(1):49-55.
1997: Lyons M J; Tyrer P; Gunderson J; Tohen M
Heuristic models of comorbidity of axis I and axis II disorders.
Journal of personality disorders 1997;11(3):260-9.
1997: Tyrer P; Gunderson J; Lyons M; Tohen M
Extent of comorbidity between mental state and personality disorders.
Journal of personality disorders 1997;11(3):242-59.
1996: Strakowski S M; Flaum M; Amador X; Bracha H S; Pandurangi A K; Robinson D; Tohen M
Racial differences in the diagnosis of psychosis.
Schizophrenia research 1996;21(2):117-24.
1996: Tohen M; Zarate C A; Centorrino F; Hegarty J I; Froeschl M; Zarate S B
Risperidone in the treatment of mania.
The Journal of clinical psychiatry 1996;57(6):249-53.
1996: Kando J C; Tohen M; Castillo J; Zarate C A
The use of valproate in an elderly population with affective symptoms.
The Journal of clinical psychiatry 1996;57(6):238-40.
1996: Kirkpatrick B; Amador X F; Yale S A; Bustillo J R; Buchanan R W; Tohen M
The deficit syndrome in the DSM-IV Field Trial. Part II. Depressive episodes and persecutory beliefs.
Schizophrenia research 1996;20(1-2):79-90.
1996: Kirkpatrick B; Amador X F; Flaum M; Yale S A; Gorman J M; Carpenter W T; Tohen M; McGlashan T
The deficit syndrome in the DSM-IV Field Trial: I. Alcohol and other drug abuse.
Schizophrenia research 1996;20(1-2):69-77.
1996: Pillay S S; Stoll A L; Weiss M K; Tohen M; Zarate C A; Banov M D; Cole J O
EEG abnormalities before clozapine therapy predict a good clinical response to clozapine.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 1996;8(1):1-5.
1996: Zarate C A; Kando J C; Tohen M; Weiss M K; Cole J O
Does intolerance or lack of response with fluoxetine predict the same will happen with sertraline?
The Journal of clinical psychiatry 1996;57(2):67-71.
1995: Zarate C A; Tohen M; Baldessarini R J
Clozapine in severe mood disorders.
The Journal of clinical psychiatry 1995;56(9):411-7.
1995: Zarate C A; Tohen M; Baraibar G; Kando J C; Mirin J
Prescribing trends of antidepressants in bipolar depression.
The Journal of clinical psychiatry 1995;56(6):260-4.
1995: Greenfield S F; Weiss R D; Tohen M
Substance abuse and the chronically mentally ill: a description of dual diagnosis treatment services in a psychiatric hospital.
Community mental health journal 1995;31(3):265-77.
1995: Zarate C A; Tohen M; Banov M D; Weiss M K; Cole J O
Is clozapine a mood stabilizer?
The Journal of clinical psychiatry 1995;56(3):108-12.
1995: Renshaw P F; Yurgelun-Todd D A; Tohen M; Gruber S; Cohen B M
Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis.
The American journal of psychiatry 1995;152(3):444-6.
1995: Tohen M; Castillo J; Baldessarini R J; Zarate C; Kando J C
Blood dyscrasias with carbamazepine and valproate: a pharmacoepidemiological study of 2,228 patients at risk.
The American journal of psychiatry 1995;152(3):413-8.
1994: Strakowski S M; Tohen M; Flaum M; Amador X
Substance abuse in psychotic disorders: associations with affective syndromes. DSM-IV Field Trial Work Group.
Schizophrenia research 1994;14(1):73-81.
1994: Stoll A L; Mayer P V; Kolbrener M; Goldstein E; Suplit B; Lucier J; Cohen B M; Tohen M
Antidepressant-associated mania: a controlled comparison with spontaneous mania.
The American journal of psychiatry 1994;151(11):1642-5.
1994: Hegarty J D; Baldessarini R J; Tohen M; Waternaux C; Oepen G
One hundred years of schizophrenia: a meta-analysis of the outcome literature.
The American journal of psychiatry 1994;151(10):1409-16.
1994: Stoll A L; Banov M; Kolbrener M; Mayer P V; Tohen M; Strakowski S M; Castillo J; Suppes T; Cohen B M
Neurologic factors predict a favorable valproate response in bipolar and schizoaffective disorders.
Journal of clinical psychopharmacology 1994;14(5):311-3.
1994: Sachs G S; Lafer B; Stoll A L; Banov M; Thibault A B; Tohen M; Rosenbaum J F
A double-blind trial of bupropion versus desipramine for bipolar depression.
The Journal of clinical psychiatry 1994;55(9):391-3.
1994: Tohen M
Applications of pharmacoepidemiology in psychiatry.
Harvard review of psychiatry 1994;2(2):117-8.
1994: Banov M D; Zarate C A; Tohen M; Scialabba D; Wines J D; Kolbrener M; Kim J W; Cole J O
Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up.
The Journal of clinical psychiatry 1994;55(7):295-300.
1994: Kando J C; Tohen M; Castillo J; Centorrino F
Concurrent use of clozapine and valproate in affective and psychotic disorders.
The Journal of clinical psychiatry 1994;55(6):255-7.
1994: Greenfield S F; Strakowski S M; Tohen M; Batson S C; Kolbrener M L
Childhood abuse in first-episode psychosis.
The British journal of psychiatry : the journal of mental science 1994;164(6):831-4.
1994: Shulman K I; Tohen M
Unipolar mania reconsidered: evidence from an elderly cohort.
The British journal of psychiatry : the journal of mental science 1994;164(4):547-9.
1994: Tohen M; Shulman K I; Satlin A
First-episode mania in late life.
The American journal of psychiatry 1994;151(1):130-2.
1994: Weiss M K; Tohen M; Zarate C; Iversen A
Diagnosis and management of bipolar II disorder.
Comprehensive therapy 1994;20(2):121-4.
1993: Banov M D; Tohen M; Friedberg J
High risk of eosinophilia in women treated with clozapine.
The Journal of clinical psychiatry 1993;54(12):466-9.
1993: Stoll A L; Tohen M; Baldessarini R J; Goodwin D C; Stein S; Katz S; Geenens D; Swinson R P; Goethe J W; McGlashan T
Shifts in diagnostic frequencies of schizophrenia and major affective disorders at six North American psychiatric hospitals, 1972-1988.
The American journal of psychiatry 1993;150(11):1668-73.
1993: Suppes T; Baldessarini R J; Faedda G L; Tondo L; Tohen M
Discontinuation of maintenance treatment in bipolar disorder: risks and implications.
Harvard review of psychiatry 1993;1(3):131-44.
1993: Strakowski S M; Stoll A L; Tohen M; Faedda G L; Goodwin D C
The Tridimensional Personality Questionnaire as a predictor of six-month outcome in first episode mania.
Psychiatry research 1993;48(1):1-8.
1993: Faedda G L; Tondo L; Baldessarini R J; Suppes T; Tohen M
Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders.
Archives of general psychiatry 1993;50(6):448-55.
1993: Strakowski S M; Tohen M; Stoll A L; Faedda G L; Mayer P V; Kolbrener M L; Goodwin D C
Comorbidity in psychosis at first hospitalization.
The American journal of psychiatry 1993;150(5):752-7.
1993: Strakowski S M; Wilson D R; Tohen M; Woods B T; Douglass A W; Stoll A L
Structural brain abnormalities in first-episode mania.
Biological psychiatry 1993;33(8-9):602-9.
1993: Strakowski S M; Woods B T; Tohen M; Wilson D R; Douglass A W; Stoll A L
MRI subcortical signal hyperintensities in mania at first hospitalization.
Biological psychiatry 1993;33(3):204-6.
1992: Tohen M; Tsuang M T; Goodwin D C
Prediction of outcome in mania by mood-congruent or mood-incongruent psychotic features.
The American journal of psychiatry 1992;149(11):1580-4.
1992: Stoll A L; Tohen M; Baldessarini R J
Increasing frequency of the diagnosis of obsessive-compulsive disorder.
The American journal of psychiatry 1992;149(5):638-40.
1992: Strakowski S M; Tohen M; Stoll A L; Faedda G L; Goodwin D C
Comorbidity in mania at first hospitalization.
The American journal of psychiatry 1992;149(4):554-6.
1992: Strakowski S M; Faedda G L; Tohen M; Goodwin D C; Stoll A L
Possible affective-state dependence of the Tridimensional Personality Questionnaire in first-episode psychosis.
Psychiatry research 1992;41(3):215-26.
1992: Shulman K I; Tohen M; Satlin A; Mallya G; Kalunian D
Mania compared with unipolar depression in old age.
The American journal of psychiatry 1992;149(3):341-5.
1992: Tohen M; Stoll A L; Strakowski S M; Faedda G L; Mayer P V; Goodwin D C; Kolbrener M L; Madigan A M
The McLean First-Episode Psychosis Project: six-month recovery and recurrence outcome.
Schizophrenia bulletin 1992;18(2):273-82.
1991: Suppes T; Baldessarini R J; Faedda G L; Tohen M
Risk of recurrence following discontinuation of lithium treatment in bipolar disorder.
Archives of general psychiatry 1991;48(12):1082-8.
1991: Tohen M; Castillo J; Cole J O; Miller M G; de los Heros R; Farrer R J
Thrombocytopenia associated with carbamazepine: a case series.
The Journal of clinical psychiatry 1991;52(12):496-8.
1991: Faedda G L; Baldessarini R J; Tohen M; Strakowski S M; Waternaux C
Episode sequence in bipolar disorder and response to lithium treatment.
The American journal of psychiatry 1991;148(9):1237-9.
1991: Strakowski S M; Hudson J I; Keck P E; Wilson D R; Frankenburg F R; Alpert J E; Teschke G C; Tohen M
Four cases of obstructive sleep apnea associated with treatment-resistant mania.
The Journal of clinical psychiatry 1991;52(4):156-8.
1988: Frankenburg F R; Tohen M; Cohen B M; Lipinski J F
Long-term response to carbamazepine: a retrospective study.
Journal of clinical psychopharmacology 1988;8(2):130-2.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Mauricio Tohen

Research Profile (preview)

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Activities & Behaviors

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Mauricio Tohen (preview)

All Publications